Role of Doxycycline in the treatment of Dengue infection in Childre
Not Applicable
- Conditions
- Health Condition 1: null- Dengue Infection
- Registration Number
- CTRI/2018/01/011548
- Lead Sponsor
- Dr Ashok H C
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
children between 8yrs and 18yrs with confirmed dengue fever
Exclusion Criteria
children in whom oral medications are contraindicated
children with known hypersensitivity to Doxycycline
Children on antiepileptic drugs
children who have recieved doxycycline elsewhere for present illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DeathTimepoint: with in 7 days or discharge from hospital which ever later
- Secondary Outcome Measures
Name Time Method Admission to hospital, IV fluid requirement, ICU admission, Need for transfusion, Progression of disease from dengue fever to DF with warning signs to Severe DengueTimepoint: 7 days from intervention